Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Ken Gatter"'
Autor:
Jina, Park, Devlynne Sasha, Ondusko, Bill H, Chang, Emily A, Edwards, Sylvia, Doan, Ken, Gatter, Ibrahim, Hajjali, Amanda, Kim
Publikováno v:
NeoReviews. 23:e861-e868
Autor:
Ken, Gatter, Mandy, VanSandt
Publikováno v:
Archives of Pathology & Laboratory Medicine. 146:1433-1434
Autor:
Ken Gatter
Publikováno v:
Archives of Pathology & Laboratory Medicine. 144:674-676
Autor:
Luke B Fletcher, Thomas G. DeLoughery, Susan L. Orloff, Grover C. Bagby, Ken Gatter, Rachel J. Cook, Jessica Leonard, Erin Maynard, Jennifer Dunlap, Richard D. Press, Kelli M. Leong, Laura F. Newell, Ali J. Olyaei, Richard T. Maziarz, C. Kristian Enestvedt, Joseph S. Bubalo
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsREFERENCES. 21(12)
Graft-versus-host disease after liver transplantation (LT-GVHD) is rare, frequently fatal, and associated with bone marrow failure (BMF), cytopenias, and hyperferritinemia. Given hyperferritinemia and cytopenias are present in hemophagocytic lymphohi
Autor:
Marc M. Loriaux, Ken Gatter, Rita M. Braziel, Guang Fan, Lauren M. Raymond, Philipp W. Raess, Jennifer Dunlap, Tracy Funk
Publikováno v:
British journal of haematologyReferences. 189(4)
Autor:
Ken Gatter, Richard D. Press, Jennifer Dunlap, C. Kristian Enestvedt, Susan L. Orloff, Richard T. Maziarz, Guang Fan, Jessica Leonard, Rachel J. Cook, Erin Maynard, Laura F. Newell
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S194
Introduction Graft-versus-host disease (GVHD) after solid organ transplant (SOT) is a rare complication with high mortality. Unique to SOT is bone marrow GVHD, with most patients dying of bone marrow failure (BMF) and subsequent sepsis. Elevated ferr
Autor:
James P. Dolan, Brett C. Sheppard, John G. Hunter, Nathan W. Bronson, Brian S. Diggs, Ken Gatter, Gene Bakis
Publikováno v:
Journal of Gastrointestinal Surgery. 19:2105-2110
A reliable method to identify pathologic complete responders (pCR) or non-responders (NR) to neoadjuvant chemoradiation therapy (NAT) would dramatically improve therapy for esophageal cancer. The purpose of this study is to investigate if a distinct
Autor:
Ken Gatter, Stephen Moore, Connie Durum, Megan L. Troxell, Helen J. Lawce, Thomas H. Long, Susan B. Olson
Publikováno v:
American Journal of Clinical Pathology. 144:253-262
Objectives: Human epidermal growth factor receptor 2 (HER2, ERBB2) testing is an important prognostic/predictive marker in breast cancer management, especially in selecting HER2-targeted treatment. American Society of Clinical Oncology (ASCO)/College
Autor:
Brett C. Sheppard, Renato A. Luna, James P. Dolan, Ken Gatter, C. A. Thomas, John G. Hunter, Molly A. Conroy, Taranjeet Kaur, Paul H. Schipper, Brian S. Diggs, John M. Holland, Gina M. Vaccaro, Gene Bakis, Brandon H. Tieu
Publikováno v:
Diseases of the Esophagus. 29:320-325
This study aimed to determine the impact of preoperative staging on the treatment of clinical T2N0 (cT2N0) esophageal cancer patients undergoing esophagectomy. We reviewed a retrospective cohort of 27 patients treated at a single institution between
Autor:
Ken Gatter
Publikováno v:
Archives of pathologylaboratory medicine. 141(6)